Wall Street brokerages expect Henry Schein, Inc. (NASDAQ:HSIC) to announce $1.11 earnings per share for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Henry Schein’s earnings. The highest EPS estimate is $1.14 and the lowest is $1.08. Henry Schein posted earnings of $0.97 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 14.4%. The company is scheduled to report its next quarterly earnings results on Tuesday, February 19th.

On average, analysts expect that Henry Schein will report full year earnings of $4.12 per share for the current year, with EPS estimates ranging from $4.10 to $4.16. For the next financial year, analysts expect that the business will report earnings of $4.41 per share, with EPS estimates ranging from $3.80 to $4.55. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Henry Schein.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 6th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.01 by $0.02. Henry Schein had a net margin of 3.00% and a return on equity of 20.40%. The company had revenue of $3.28 billion for the quarter, compared to the consensus estimate of $3.37 billion. During the same period in the prior year, the company posted $0.87 EPS. The company’s revenue was up 3.8% compared to the same quarter last year.

A number of research analysts have issued reports on HSIC shares. Goldman Sachs Group restated a “neutral” rating on shares of Henry Schein in a research report on Friday, October 19th. Morgan Stanley upped their target price on shares of Henry Schein from $65.00 to $66.00 and gave the company an “underweight” rating in a research report on Tuesday, October 9th. BidaskClub downgraded shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 23rd. ValuEngine upgraded shares of Henry Schein from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 13th. Finally, Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, August 2nd. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $84.41.

Several hedge funds have recently made changes to their positions in HSIC. FMR LLC increased its stake in shares of Henry Schein by 167.3% in the 2nd quarter. FMR LLC now owns 6,632,783 shares of the company’s stock valued at $481,805,000 after acquiring an additional 4,151,179 shares during the last quarter. Point72 Asset Management L.P. increased its stake in Henry Schein by 2,573.5% during the 2nd quarter. Point72 Asset Management L.P. now owns 802,047 shares of the company’s stock worth $58,261,000 after purchasing an additional 772,047 shares in the last quarter. Atlanta Capital Management Co. L L C increased its stake in Henry Schein by 19.0% during the 3rd quarter. Atlanta Capital Management Co. L L C now owns 2,924,653 shares of the company’s stock worth $248,683,000 after purchasing an additional 466,704 shares in the last quarter. American Century Companies Inc. increased its stake in Henry Schein by 21.2% during the 2nd quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock worth $159,202,000 after purchasing an additional 383,479 shares in the last quarter. Finally, Glenmede Trust Co. NA increased its stake in Henry Schein by 11,084.6% during the 2nd quarter. Glenmede Trust Co. NA now owns 355,000 shares of the company’s stock worth $25,787,000 after purchasing an additional 351,826 shares in the last quarter.

Henry Schein stock traded up $0.03 during trading hours on Friday, reaching $86.07. 1,239,283 shares of the company’s stock traded hands, compared to its average volume of 1,401,155. The company has a current ratio of 1.30, a quick ratio of 0.70 and a debt-to-equity ratio of 0.29. Henry Schein has a fifty-two week low of $62.56 and a fifty-two week high of $90.52. The company has a market cap of $13.12 billion, a PE ratio of 23.91, a PEG ratio of 2.72 and a beta of 0.87.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: 52-Week High/Low

Get a free copy of the Zacks research report on Henry Schein (HSIC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.